These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6315398)

  • 1. Calcium channels: evidence for oligomeric nature by target size analysis.
    Ferry DR; Goll A; Glossmann H
    EMBO J; 1983; 2(10):1729-32. PubMed ID: 6315398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular approach to the calcium channel.
    Glossmann H; Ferry DR; Goll A; Linn T
    Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine.
    Glossmann H; Ferry DR
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):279-91. PubMed ID: 6314149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of putative calcium channels in skeletal muscle microsomes.
    Ferry DR; Glossmann H
    FEBS Lett; 1982 Nov; 148(2):331-7. PubMed ID: 6295810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation.
    Goll A; Ferry DR; Glossmann H
    FEBS Lett; 1983 Jun; 157(1):63-9. PubMed ID: 6305718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of multiple receptor sites within the putative calcium channel.
    Ferry DR; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Oct; 321(1):80-3. PubMed ID: 6292744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
    Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H
    FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubilization and affinity labeling of a dihydropyridine binding site from skeletal muscle: effects of temperature and diltiazem on [3H]dihydropyridine binding to transverse tubules.
    Kirley TL; Schwartz A
    Biochem Biophys Res Commun; 1984 Aug; 123(1):41-9. PubMed ID: 6089800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of voltage operated calcium channels by binding studies: differentiation of subclasses of calcium antagonist drugs with 3H-nimodipine radioligand binding.
    Glossmann H; Ferry DR; Lübbecke F; Mewes R; Hofmann F
    J Recept Res; 1983; 3(1-2):177-90. PubMed ID: 6304295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists.
    Glossmann H; Linn T; Rombusch M; Ferry DR
    FEBS Lett; 1983 Aug; 160(1-2):226-32. PubMed ID: 6309565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.
    Glossmann H; Ferry DR; Goll A; Rombusch M
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S608-21. PubMed ID: 6083403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
    Staudinger R; Knaus HG; Glossmann H
    J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified calcium channels have three allosterically coupled drug receptors.
    Striessnig J; Goll A; Moosburger K; Glossmann H
    FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between calcium channel ligands and calcium channels.
    Glossmann H; Striessnig J; Ferry DR; Goll A; Moosburger K; Schirmer M
    Circ Res; 1987 Oct; 61(4 Pt 2):I30-6. PubMed ID: 2443273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are dihydropyridine binding sites voltage sensitive calcium channels?
    Miller RJ; Freedman SB
    Life Sci; 1984 Mar; 34(13):1205-21. PubMed ID: 6323901
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of the binding sites for nimodipine and (-)-desmethoxyverapamil in bovine cardiac sarcolemma.
    Ruth P; Flockerzi V; von Nettelbladt E; Oeken J; Hofmann F
    Eur J Biochem; 1985 Jul; 150(2):313-22. PubMed ID: 2990931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channels: basic properties as revealed by radioligand binding studies.
    Glossmann H; Ferry DR; Goll A; Striessnig J; Schober M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S20-30. PubMed ID: 2414589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
    Messing RO; Carpenter CL; Greenberg DA
    J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.